 |
PDBsum entry 5inh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
5inh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.3.1.4.39
- alkylglycerophosphoethanolamine phosphodiesterase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1-O-alkyl-sn-glycero-3-phosphoethanolamine + H2O = a 1-O-alkyl- sn-glycero-3-phosphate + ethanolamine + H+
|
 |
 |
 |
 |
 |
1-O-alkyl-sn-glycero-3-phosphoethanolamine
|
+
|
H2O
|
=
|
1-O-alkyl- sn-glycero-3-phosphate
|
+
|
ethanolamine
Bound ligand (Het Group name = )
matches with 60.00% similarity
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.1.4.4
- phospholipase D.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1,2-diacyl-sn-glycero- 3-phosphate + choline + H+
|
 |
 |
 |
 |
 |
1,2-diacyl-sn-glycero-3-phosphocholine
|
+
|
H2O
|
=
|
1,2-diacyl-sn-glycero- 3-phosphate
|
+
|
choline
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
60:5209-5215
(2017)
|
|
PubMed id:
|
|
|
|
|
| |
|
Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes.
|
|
M.Lanier,
D.C.Cole,
Y.Istratiy,
M.G.Klein,
P.A.Schwartz,
R.Tjhen,
A.Jennings,
M.S.Hixon.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Serine hydrolases are susceptible to potent reversible inhibition by boronic
acids. Large collections of chemically diverse boronic acid fragments are
commercially available because of their utility in coupling chemistry. We
repurposed the approximately 650 boronic acid reagents in our collection as a
directed fragment library targeting serine hydrolases and related enzymes.
Highly efficient hits (LE > 0.6) often result. The utility of the approach is
illustrated with the results against autotaxin, a phospholipase implicated in
cardiovascular disease.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |